An Optimized Evans Blue Protocol to Assess Vascular Leak in the Mouse.

J Vis Exp

Cardiovascular Pulmonary Research Laboratory, University of Colorado Denver; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver; Denver VA Medical Center.

Published: September 2018

Vascular leak, or plasma extravasation, has a number of causes, and may be a serious consequence or symptom of an inflammatory response. This study may ultimately lead to new knowledge concerning the causes of or new ways to inhibit or treat plasma extravasation. It is important that researchers have the proper tools, including the best methods available, for studying plasma extravasation. In this article, we describe a protocol, using the Evans blue dye method, for assessing plasma extravasation in the organs of FVBN mice. This protocol is intentionally simple, to as great a degree as possible, but provides high quality data. Evans blue dye has been chosen primarily because it is easy for the average laboratory to use. We have used this protocol to provide evidence and support for the hypothesis that the enzyme neprilysin may protect the vasculature against plasma extravasation. However, this protocol may be experimentally used and easily adapted for use in other strains of mice or in other species, in many different organs or tissues, for studies which may involve other factors that are important in understanding, preventing, or treating plasma extravasation. This protocol has been extensively optimized and modified from existing protocols, and combines reliability, ease of use, economy, and general availability of materials and equipment, making this protocol superior for the average laboratory to use in quantifying plasma extravasation from organs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235160PMC
http://dx.doi.org/10.3791/57037DOI Listing

Publication Analysis

Top Keywords

plasma extravasation
28
evans blue
12
vascular leak
8
blue dye
8
extravasation organs
8
average laboratory
8
extravasation protocol
8
protocol
7
plasma
7
extravasation
7

Similar Publications

Extracellular Vesicles From Preeclampsia Disrupt the Blood-Brain Barrier by Reducing CLDN5.

Arterioscler Thromb Vasc Biol

December 2024

Vascular Physiology Laboratory, Department of Basic Sciences, Universidad del Bío-Bío, Chillán, Chile (H.S., B.I., M.C., F.T., E.E.-G., J.A., C.E.).

Background: The physiopathology of life-threatening cerebrovascular complications in preeclampsia is unknown. We investigated whether disruption of the blood-brain barrier, generated using circulating small extracellular vesicles (sEVs) from women with preeclampsia or placentae cultured under hypoxic conditions, impairs the expression of tight junction proteins, such as CLDN5 (claudin-5), mediated by VEGF (vascular endothelial growth factor), and activation of KDR (VEGFR2 [VEGF receptor 2]).

Methods: We perform a preclinical mechanistic study using sEVs isolated from plasma of pregnant women with normal pregnancy (sEVs-NP; n=9), sEVs isolated from plasma of women with preeclampsia (sEVs-PE; n=9), or sEVs isolated from placentas cultured in normoxia (sEVs-Nor; n=10) or sEVs isolated from placentas cultured in hypoxia (sEVs-Hyp; n=10).

View Article and Find Full Text PDF

A 56-year-old female with class 3 obesity, was previously submitted to laparoscopic sleeve gastrectomy (LSG) two weeks before current admission. The patient was admitted due to fever, abdominal pain and vomiting. CT revealed a 13.

View Article and Find Full Text PDF
Article Synopsis
  • Superficial mucoceles (SM) are benign, small vesicles in the oral mucosa caused by salivary gland duct rupture, often found on the lower lip.
  • Immune checkpoint blockade treatments used in cancer can lead to skin-related side effects in 40-50% of patients, with severe cases occurring in 1-2%, such as Stevens-Johnson syndrome.
  • A case study highlighted the successful treatment of multiple SM in a patient with squamous cell carcinoma, utilizing plasma and electrocoagulation methods, and aimed to improve understanding of mucosal reactions to cancer therapies.
View Article and Find Full Text PDF

NON-INVASIVE METHOD OF MONITORING INTRACRANIAL PRESSURE FOR THE EVALUATION OF HEPATIC ENCEPHALOPATHY.

Arq Gastroenterol

November 2024

Faculdade de Medicina de São José do Rio Preto, Departamento de Cardiologia e Cirurgia Cardiovascular, São José do Rio Preto, São Paulo , Brasil.

Article Synopsis
  • The study investigates a new non-invasive method for monitoring intracranial pressure (ICP) in patients with liver diseases and hepatic encephalopathy (HE), aiming to provide an alternative to invasive techniques.
  • It uses a specific equipment, Brain4Care® BWS, to analyze ICP pulse morphology and correlates it with clinical signs of HE, focusing on key peaks that indicate intracranial compliance.
  • Results show significant differences in ICP patterns between patients with and without HE, highlighting the method's potential for effective monitoring and assessment in clinical settings.
View Article and Find Full Text PDF

Systemic capillary leak syndrome.

Nat Rev Dis Primers

November 2024

Division of Nephrology, Departments of Internal Medicine and Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

The vascular endothelial barrier maintains intravascular volume and metabolic homeostasis. Although plasma fluids and proteins extravasate continuously from tissue microvasculature (capillaries, post-capillary venules), systemic vascular leakage increases in critical illness associated with sepsis, burns and trauma, among others, or in association with certain drugs or toxin exposures. Systemically dysregulated fluid homeostasis, which can lead to hypovolaemia, hypotensive shock and widespread tissue oedema, has been termed systemic capillary leak syndrome (SCLS) when overt secondary causes (for example, heart or liver failure) are excluded.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!